|
PARN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.364860E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.156100E-02 |
| Normal-vs-Stage2 |
2.614400E-01 |
| Normal-vs-Stage3 |
7.844500E-03 |
| Normal-vs-Stage4 |
5.98589999999399E-05 |
| Stage1-vs-Stage2 |
7.774400E-01 |
| Stage1-vs-Stage3 |
3.390600E-01 |
| Stage1-vs-Stage4 |
2.517600E-03 |
| Stage2-vs-Stage3 |
3.689200E-01 |
| Stage2-vs-Stage4 |
2.272300E-02 |
| Stage3-vs-Stage4 |
5.300300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.595900E-03 |
| Normal-vs-AfricanAmerican |
1.609970E-02 |
| Normal-vs-Asian |
4.924100E-02 |
| Caucasian-vs-AfricanAmerican |
3.771800E-01 |
| Caucasian-vs-Asian |
3.774400E-02 |
| AfricanAmerican-vs-Asian |
1.372040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.559600E-03 |
| Normal-vs-Female |
7.598800E-04 |
| Male-vs-Female |
2.550000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.503650E-01 |
| Normal-vs-Age(41-60Yrs) |
7.968300E-04 |
| Normal-vs-Age(61-80Yrs) |
9.222800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.870800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.721600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.320200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.488400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.438000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.082830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.138400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.414600E-01 |
| Normal-vs-Grade 2 |
1.002440E-01 |
| Normal-vs-Grade 3 |
4.780600E-03 |
| Normal-vs-Grade 4 |
4.02710000013684E-07 |
| Grade 1-vs-Grade 2 |
7.969000E-01 |
| Grade 1-vs-Grade 3 |
8.219200E-01 |
| Grade 1-vs-Grade 4 |
8.789900E-02 |
| Grade 2-vs-Grade 3 |
1.704020E-01 |
| Grade 2-vs-Grade 4 |
2.10370000000015E-05 |
| Grade 3-vs-Grade 4 |
9.579400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.655160E-01 |
| Normal-vs-ccB subtype |
6.22019999999557E-05 |
| ccA subtype-vs-ccB subtype |
1.303080E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.679810E-03 |
| Normal-vs-N1 |
5.044400E-04 |
| N0-vs-N1 |
1.084780E-03 |
|
|
